Patients using Lercanidipine HCI 20 mg tablets manufactured by Recordati Pharmaceuticals Limited are advised to immediately inspect their medication for a specific batch number, MD4L07, with an expiry date of January 2028. An issue regarding the labeling of the medicine's strength has been identified, affecting only one batch. The packaging mistakenly indicates a 10 mg dosage on some sides while containing 20 mg tablets. Despite this error, the correct dosage is printed on other parts of the packaging. Guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises patients prescribed 10 mg to contact their healthcare provider or pharmacist if they possess this batch. Emergency advice is available through NHS 111. For those prescribed 20 mg, verification of the tablet strength before consumption is essential.

Medication Labeling Issue Affects Specific Batch

In the heart of an ongoing effort to ensure patient safety, a significant alert was issued by the MHRA concerning a labeling discrepancy in a particular batch of Lercanidipine HCI tablets. This situation arose after Recordati Pharmaceuticals Limited notified authorities about an inconsistency involving the strength indication on certain packaging sides. The problem is confined exclusively to batch MD4L07, which displays an incorrect 10 mg label despite containing 20 mg tablets. Patients prescribed the lower dose are urged to consult healthcare professionals or divide the tablets as a temporary measure until further instructions are received. Those on the higher dose should confirm the tablet strength prior to ingestion. The manufacturer has initiated a recall to address the issue proactively.

From a journalist's perspective, this incident highlights the critical importance of vigilant quality control in pharmaceutical manufacturing. It underscores the necessity for both manufacturers and regulatory bodies to maintain robust communication channels, ensuring rapid dissemination of crucial information to protect public health. For readers, it serves as a reminder of the significance of carefully checking medication details and promptly seeking professional advice when discrepancies arise. Such vigilance can prevent potential health risks associated with incorrect dosages.